Quick Answer
IMPACT BIOMEDICAL INC. reported Operating Income of -$4.28 million for fiscal year 2025.
IMPACT BIOMEDICAL INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.28M | +85.1% |
| 2024 | -$28.75M | -613.8% |
| 2023 | -$4.03M | -18.3% |
| 2022 | -$3.40M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$948.0K | +15.9% | +17.8% |
| June 30, 2025 | -$1.15M | -84.2% | -14.2% |
| March 31, 2025 | -$1.01M | -31.0% | +10.4% |
| September 30, 2024 | -$1.13M | -4.5% | -80.0% |
| June 30, 2024 | -$626.0K | +37.9% | +18.8% |
| March 31, 2024 | -$771.0K | +4.0% | +28.5% |
| September 30, 2023 | -$1.08M | -21.3% | -6.9% |
| June 30, 2023 | -$1.01M | -34.4% | -25.5% |
- IMPACT BIOMEDICAL INC. showed an increase of +85.1% in Operating Income compared to the prior fiscal year.
- Over the 2022–2025 period, IMPACT BIOMEDICAL INC.’s operating income has declined by 25.8% (from -$3.40 million to -$4.28 million).
- The most recent figure is from IMPACT BIOMEDICAL INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: